Table of Content

Part 1. Introduction
1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment
Part 2. Methodology
2.1 Primary
2.2 Secondary
Part 3. Executive Summary

Part 4. Market Overview
4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Smart Insulin or Glucose Responsive Insulin by Delivery Devices
5.1 Smart Insulin Pens
5.1.1 Market Size and Forecast
5.2 Smart Insulin Pumps
5.2.1 Market Size and Forecast

Part 6. Global Market for Smart Insulin or Glucose Responsive Insulin by Disease
6.1 Type 1 Diabetes
6.1.1 Market Size and Forecast
6.2 Type 2 Diabetes
6.2.1 Market Size and Forecast

Part 7. Global Market for Smart Insulin or Glucose Responsive Insulin by Type
7.1 Intermediate-Acting Insulin
7.1.1 Market Size and Forecast
7.2 Long-Acting Insulin
7.2.1 Market Size and Forecast
7.3 Pre-Mixed Insulin
7.3.1 Market Size and Forecast
7.4 Rapid-Acting Insulin
7.4.1 Market Size and Forecast
7.5 Short-Acting Insulin
7.5.1 Market Size and Forecast

Part 8. Global Market for Smart Insulin or Glucose Responsive Insulin by Region
8.1 Asia-Pacific
8.1.1 Market Size and Forecast
8.2 Europe
8.2.1 Market Size and Forecast
8.3 North America
8.3.1 Market Size and Forecast
8.4 Middle East And Africa (Mea)
8.4.1 Market Size and Forecast
8.5 South America
8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles
9.1 Diamesco Co., Ltd.
9.2 Eli Lily and Company
9.3 Insulet Corporation
9.4 Medtronic Plc
9.5 Novo Nordisk A/S
9.6 Roche Holding AG
9.7 Sanofi S.A.
9.8 Tandem Diabetes Care, Inc.
9.9 Zealand Pharma A/S
*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis
10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY